| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 34PHS7TU43 |
| InChI Key | PFTAWBLQPZVEMU-UKRRQHHQSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H14O6 |
| Molecular Weight | 290.27 |
| AlogP | 1.55 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 110.38 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 1376 | - | 200 | 0.47 | |
|
Enzyme
Oxidoreductase
|
2 | 2000-12200 | 25900 | - | 41 | |
|
Enzyme
Phosphatase
|
51300 | 1360 | - | - | 78.28-170.62 | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A1A subfamily
|
- | 4500 | - | - | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 150000 | 5190000 | - | - | |
|
Enzyme
Transferase
|
- | - | - | - | 8.66-83.11 | |
|
Enzyme
|
2 | 2000-12200 | 25900 | 200 | 78.28-170.62 | |
|
Membrane receptor
|
- | 5300 | - | - | - | |
|
Other nuclear protein
|
- | 1450 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 77.92 | |
|
Unclassified protein
|
- | 800-29900 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Muscular Dystrophy, Duchenne | 2 | D020388 | ClinicalTrials |
| Hypertension, Pulmonary | 1 | D006976 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 90 |
| ChEMBL | CHEMBL583912 |
| DrugBank | DB12039 |
| EPA CompTox | DTXSID4045133 |
| FDA SRS | 34PHS7TU43 |
| Human Metabolome Database | HMDB01871 |
| KEGG | C09727 |
| PDB | 28E |
| PubChem | 72276 |
| SureChEMBL | SCHEMBL19412 |
| ZINC | ZINC000000119988 |